James B. Tananbaum, Director at CRITICAL THERAPEUTICS INC (CRTX), sold 1,102,167 shares at $2.90 ($3.1M) on 2007-06-01, disclosed to the SEC on 2007-06-05.
Open-market sale of $3.1M CRTX by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $2.90 | 398,894 | $1.2M | 37.8% |
| 2 | $2.76 | 315,773 | $872K | 28.5% |
| 3 | $2.66 | 387,500 | $1.0M | 33.7% |
| Total | $2.78 avg | 1,102,167 | $3.1M | 100% |
| Filing → |
| CRTX | SELL | 2007-06-08 | $1.6M | — | Filing → |
| VNDA | SELL | 2006-12-13 | $19.8M | — | Filing → |